Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2021.0308


Developing new clinical predictions to optimize colorectal cancer treatment.

A. Encke, MD, PhD.


Development of non-invasive screening and biomarkers to precisely predict drug response in individual patients with colorectal cancer (CRC) represents an emerging goal of breakthrough research [1]. We discuss the potential and challenges of novel spatiotemporal genome and transcriptome analysis to detect tumoral and liquid biomarkers in CRC patients [2].

(Citation: Gastric & Breast Cancer 2021; 16(1): 72-78)

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 1 January 2021